Intravitreal triamcinolone acetonide for the management of diabetic papillopathy.
OBJECTIVE
To present a case of severe drop in vision in both eyes caused by diabetic papillopathy that was treated with an intravitreal injection of triamcinolone acetonide.


METHODS
Interventional case report.


METHODS
A diabetic patient with bilateral diabetic papillopathy and drop in vision received sequential intravitreal triamcinolone acetonide injections to both eyes.


RESULTS
Within 2 weeks of intravitreal injection, vision improved from counting fingers at 1 m to 20/50 OS, and from counting fingers at 4 m to 20/40 OD. This improvement was accompanied by resolution of disk swelling and macular edema. Vision remained stable in both eyes at 20/40 for 8 months of follow-up. No elevation of intraocular pressure beyond 21 mm Hg was noted at any time.


CONCLUSIONS
Diabetic papillopathy with severe drop in vision can be treated with intravitreal triamcinolone acetonide injection.
Al-Haddad
Christiane E
CE
Department of Ophthalmology, American University of Beirut Medical Center, Beirut, Lebanon.
Jurdi
Fadi A
FA
Bashshur
Ziad F
ZF
D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D003929:Diabetic Neuropathies / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D005451:Fluorescein Angiography; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007267:Injections; D007429:Intraocular Pressure; D008297:Male; D008875:Middle Aged; D010211:Papilledema / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D014222:Triamcinolone Acetonide / Q000627:therapeutic use*; D014792:Visual Acuity; D014822:Vitreous Body / Q000187:drug effects
D005938:Glucocorticoids; D014222:Triamcinolone Acetonide